Cardiac toxicities of lapatinib in patients with breast cancer and other HER2-positive cancers: a meta-analysis
Sign Up to like & getrecommendations! Published in 2017 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-017-4460-9
Abstract: PurposeLapatinib is a tyrosine kinase inhibitor that targets the human epidermal growth factor receptor 2 (HER2) and the epidermal growth factor receptor (EGFR/HER1), and there are concerns about its cardiac toxicity. Recent studies of lapatinib… read more here.
Keywords: patients breast; cardiac adverse; breast cancer; adverse events ... See more keywords
Evaluation of cardiac adverse events with ponatinib using a spontaneous reporting database.
Sign Up to like & getrecommendations! Published in 2023 at "Oncology"
DOI: 10.1159/000529768
Abstract: INTRODUCTION The efficacy of ponatinib was demonstrated in patients resistant or intolerant to prior BCR-ABL tyrosine kinase inhibitors. However, cardiac adverse events (CAEs) have become a concern as a serious side effect of ponatinib administration.… read more here.
Keywords: hypertension; database; cardiac failure; myocardial infarction ... See more keywords
Higher neutrophil to lymphocyte ratio is associated with renal dysfunction and cardiac adverse remodeling in elderly with metabolic syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.921204
Abstract: Background Previous studies have shown that metabolic syndrome (MetS) is associated with increased systemic inflammation and cardiac mortality in elderly subjects. However, information on the association of inflammation markers with cardiac adverse remodeling is limited… read more here.
Keywords: adverse remodeling; lymphocyte ratio; metabolic syndrome; elderly mets ... See more keywords
Multimarker Approach to Identify Patients with Coronary Artery Disease at High Risk for Subsequent Cardiac Adverse Events: The Multi-Biomarker Study
Sign Up to like & getrecommendations! Published in 2020 at "Biomolecules"
DOI: 10.3390/biom10060909
Abstract: In our prospective non-randomized, single-center cohort study (n = 161), we have evaluated a multimarker approach including S100 calcium binding protein A12 (S100A1), interleukin 1 like-receptor-4 (IL1R4), adrenomedullin, copeptin, neutrophil gelatinase-associated lipocalin (NGAL), soluble urokinase… read more here.
Keywords: risk; adverse events; subsequent cardiac; cardiac adverse ... See more keywords
Intravenous Versus Wetting Solution Magnesium Sulphate to Counteract Epinephrine Cardiac Adverse Events in Abdominal Liposuction: A Randomized Controlled Trial
Sign Up to like & getrecommendations! Published in 2022 at "Anesthesiology and Pain Medicine"
DOI: 10.5812/aapm-129807
Abstract: Background The increased frequency of liposuction has resulted in more complications being reported. Adding epinephrine to the wetting solution could induce some cardiac adverse effects, some of which may be fatal. For instance, magnesium sulfate… read more here.
Keywords: wetting solution; liposuction; group; cardiac adverse ... See more keywords